New neutralizing antibody epitopes in hepatitis C virus envelope glycoproteins are revealed by dissecting peptide recognition profiles.
about
In Silico Identification and Conservation Analysis of B-cell and T-Cell Epitopes of Hepatitis C Virus 3a Genotype Enveloped Glycoprotein 2 From Pakistan: A Step Towards Heterologous Vaccine DesignIdentification of conserved residues in hepatitis C virus envelope glycoprotein E2 that modulate virus dependence on CD81 and SRB1 entry factors.The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development.Reverse Engineering of Vaccine Antigens Using High Throughput Sequencing-enhanced mRNA DisplayAntibodies to an interfering epitope in hepatitis C virus E2 can mask vaccine-induced neutralizing activityVaccination with the recombinant major outer membrane protein elicits antibodies to the constant domains and induces cross-serovar protection against intranasal challenge with Chlamydia trachomatis.Inhibition of hepatitis C virus by the cyanobacterial protein Microcystis viridis lectin: mechanistic differences between the high-mannose specific lectins MVL, CV-N, and GNA.Virus-neutralizing antibodies to hepatitis C virus.Challenges to the development of vaccines to hepatitis C virus that elicit neutralizing antibodies.Structure-function analysis of hepatitis C virus envelope glycoproteins E1 and E2.Non-neutralizing epitopes induce robust hepatitis C virus (HCV)-specific antibody-dependent CD56+ natural killer cell responses in chronic HCV-infected patients.Variation analysis of E1 and E2 in HCV subtypes.A chimeric protein encompassing hepatitis C virus epitopes is able to elicit both humoral and cell-mediated immune responses in mice.Determinants in the IgV Domain of human HAVCR1 (TIM-1) are required to enhance Hepatitis C Virus Entry.A protein coevolution method uncovers critical features of the Hepatitis C Virus fusion mechanism.
P2860
Q33808123-42E3274F-F8B5-4871-9BF1-9DFA32ECB1F4Q34262175-35942EF9-B31A-4DF0-B59F-C940464B9C29Q34481429-1EAA4AC1-2D09-474B-BAE2-89C8FB78C8CCQ35794740-6E34E85C-3A85-45EE-9991-3181D76B6344Q36378193-FF636DD5-BD31-4C62-9274-7EA10AE16852Q36827004-BA734B90-0FED-44C8-A79E-0F5DD9AC69DDQ37533386-1A608E9A-EBC7-4F55-88BA-459960E52DD3Q38104471-0F55C53F-E15F-454A-9840-384E463C2DB1Q38234934-5729A24F-C947-48B2-877F-418E9DD2F4EFQ40189989-99C25CC3-55E8-41AC-9A1F-C83FA9F28B22Q40286085-A2DBFBF9-6071-465A-B55A-A4023B1DB21EQ41096636-0F347F6B-2445-43C3-A4A0-2AE1AAEA0880Q42234870-EE975B50-DB1B-4598-A351-2800C73E64BBQ47555918-7F83F7B9-9688-496F-B91F-72AAE3BCDBC3Q51149647-2BDC9B30-415A-4933-8E18-9DC131763EA8
P2860
New neutralizing antibody epitopes in hepatitis C virus envelope glycoproteins are revealed by dissecting peptide recognition profiles.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
New neutralizing antibody epit ...... peptide recognition profiles.
@en
New neutralizing antibody epit ...... peptide recognition profiles.
@nl
type
label
New neutralizing antibody epit ...... peptide recognition profiles.
@en
New neutralizing antibody epit ...... peptide recognition profiles.
@nl
prefLabel
New neutralizing antibody epit ...... peptide recognition profiles.
@en
New neutralizing antibody epit ...... peptide recognition profiles.
@nl
P2093
P1433
P1476
New neutralizing antibody epit ...... peptide recognition profiles.
@en
P2093
Aleksander Shvalov
Alla Ivanova
Alla Kachko
Antonina Grazhdantseva
Frances Wells
Galina Kochneva
Galina Sivolobova
Hisayoshi Watanabe
Iryna Zubkova
Marian E Major
P356
10.1016/J.VACCINE.2011.10.045
P407
P577
2011-10-29T00:00:00Z